S&P 500
(-0.46%) 5 048.42 points
Dow Jones
(-0.98%) 38 086 points
Nasdaq
(-0.64%) 15 612 points
Oil
(0.30%) $83.82
Gas
(-2.38%) $1.599
Gold
(0.23%) $2 348.00
Silver
(0.50%) $27.49
Platinum
(0.98%) $929.50
USD/EUR
(0.08%) $0.932
USD/NOK
(0.11%) $10.96
USD/GBP
(0.06%) $0.800
USD/RUB
(0.02%) $92.18

Realtime updates for MediPal Holdings [7459.T]

Exchange: JPX Sector: Healthcare Industry: Medical Distribution
Last Updated25 Apr 2024 @ 22:07

1.08% ¥ 2 439.00

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 22:07):

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products...

Stats
Today's Volume 157 600
Average Volume 618 386
Market Cap 512.23B
EPS ¥0 ( 2024-02-04 )
Next earnings date ( ¥41.18 ) 2024-05-13
Last Dividend ¥23.00 ( 2023-03-30 )
Next Dividend ¥0 ( N/A )
P/E 13.98
ATR14 ¥1.188 (0.05%)

Volume Correlation

Long: -0.44 (neutral)
Short: 0.11 (neutral)
Signal:(32.345) Neutral

MediPal Holdings Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MediPal Holdings Correlation - Currency/Commodity

The country flag 0.53
( weak )
The country flag -0.35
( neutral )
The country flag -0.24
( neutral )
The country flag 0.35
( neutral )
The country flag 0.52
( weak )
The country flag -0.39
( neutral )

MediPal Holdings Financials

Annual 2022
Revenue: ¥3 360.01B
Gross Profit: ¥224.31B (6.68 %)
EPS: ¥184.82
Q3 2023
Revenue: ¥935.93B
Gross Profit: ¥65.30B (6.98 %)
EPS: ¥52.80
Q2 2023
Revenue: ¥892.25B
Gross Profit: ¥62.04B (6.95 %)
EPS: ¥28.08
Q1 2023
Revenue: ¥886.74B
Gross Profit: ¥59.34B (6.69 %)
EPS: ¥52.32

Financial Reports:

No articles found.

MediPal Holdings Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥23.00
(N/A)
¥0
(N/A)
¥23.00
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

MediPal Holdings Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.56 - average (52.54%) | Divividend Growth Potential Score: 4.60 - Stable (8.04%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend ¥6.00 2001-03-27
Last Dividend ¥23.00 2023-03-30
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 46 --
Total Paid Out ¥539.00 --
Avg. Dividend % Per Year 0.00% --
Score 2.98 --
Div. Sustainability Score 5.56
Div.Growth Potential Score 4.60
Div. Directional Score 5.08 --
Next Divdend (Est)
(2024-07-03)
¥0 Estimate 1.26 %
Dividend Stability
0.10 Bad
Dividend Score
2.98
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
8137.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
7487.T Ex Dividend Junior 2024-05-30 Annually 0 0.00%
6715.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
6059.T Ex Dividend Junior 2023-09-28 Annually 0 0.00%
4739.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
3983.T Ex Dividend Knight 2023-12-28 Annually 0 0.00%
3193.T Ex Dividend Junior 2024-01-30 Annually 0 0.00%
2183.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
9055.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
7943.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.01061.5009.7910.00[0 - 0.5]
returnOnAssetsTTM0.01991.2009.3410.00[0 - 0.3]
returnOnEquityTTM0.06461.500-0.393-0.590[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.1980.8009.017.21[1 - 3]
quickRatioTTM0.9280.8009.257.40[0.8 - 2.5]
cashRatioTTM0.1941.500-0.0355-0.0533[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM2 432.801.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM259.542.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM259.542.0010.0010.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.06851.000-2.19-2.19[0.2 - 0.8]
operatingProfitMarginTTM0.01391.000-1.723-1.723[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM1.8720.8000.8540.683[0.5 - 2]
Total Score5.56

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM13.661.0008.720[1 - 100]
returnOnEquityTTM0.06462.50-0.253-0.590[0.1 - 1.5]
freeCashFlowPerShareTTM259.542.0010.0010.00[0 - 30]
dividendYielPercentageTTM2.491.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM259.542.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.5941.5009.370[0.5 - 2]
operatingCashFlowSalesRatioTTM0.01561.000-2.110[0.1 - 0.5]
Total Score4.60

MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators